Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,392 | 26,678 | 34,186 | 24,062 | 40,031 |
| Marketable Securities | 4,925 | 20,296 | 19,486 | 35,326 | 25,232 |
| TOTAL | $42,755 | $48,723 | $54,906 | $60,441 | $66,608 |
| Non-Current Assets | |||||
| PPE Net | 372 | 396 | 374 | 208 | 224 |
| Other Non-Current Assets | 393 | 276 | 383 | 693 | 706 |
| TOTAL | $765 | $672 | $757 | $901 | $930 |
| Total Assets | $43,520 | $49,395 | $55,663 | $61,342 | $67,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 556 | 591 | 527 | 431 | 1,020 |
| Accrued Expenses | 4,523 | 4,186 | 3,970 | 2,838 | 2,576 |
| Other current liabilities | N/A | 98 | 241 | 319 | 537 |
| TOTAL | $5,079 | $4,942 | $4,738 | $3,588 | $4,133 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,079 | $4,942 | $4,738 | $3,588 | $4,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 415 | 415 | 415 | 414 | 413 |
| Common Shares | 17 | 17 | 16 | 16 | 16 |
| Retained earnings | -159,777 | -152,815 | -145,708 | -137,803 | -131,251 |
| Other shareholders' equity | 0 | -59 | 10 | 12 | -11 |
| TOTAL | $38,441 | $44,453 | $50,925 | $57,754 | $63,405 |
| Total Liabilities And Equity | $43,520 | $49,395 | $55,663 | $61,342 | $67,538 |